Apheresis Equipment Market – Global Industry Analysis and Forecast 2023 – 2029

Apheresis Equipment Market size is expected to reach nearly US$ 7.48 Bn. by 2029 with the CAGR of 10.9% during the forecast period. Due to some major factors including rising cases of cardiovascular diseases, increasing demand for automation in the separation of blood components, high demand for advanced technologies, high investment from the government for healthcare infrastructure and increasing rate of platelet donors. However, increasing cost for the products is expected to hamper the apheresis equipment market growth through 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Global Apheresis Equipment MarketTo know about the Research Methodology:-Request Free Sample Report A rising rate of cardiovascular diseases including cell anaemia and leukaemia are the primary factor driving the apheresis equipment market through the forecast period. Some technological advancements such as screen navigation, continuous flow centrifugation, customized anticoagulant infusion system, automated interface system, and GUI display also drive the market for apheresis equipment. North America is having the highest market share for apheresis equipment’s is primarily due to high support from U.S. government. The U.S. is the major country contributes more than 80% in North American region due to high investment from the government on the research and development activities on various apheresis equipment and increased adoption of advanced technology in the healthcare sector. Asia-Pacific has the highest growth rate, primarily due to a rising rate of cardiovascular diseases and increasing development in the healthcare sector. Japan have the highest market for apheresis equipment’s in the Asia-Pacific region due to the increasing percentage of blood cancers, a rising rate of cardiovascular disorders in the country and adoption of advanced technology in the healthcare sector. By process, plasmapheresis segment had the highest market share, primarily due to rising cases of hematological problems, and cardiovascular disorders. These two cases need the plasma transmission from a healthy person to sick person and thus, increase the market for plasmapheresis. Further, increasing demand for plasma transmission also drives the market for plasmapheresis through the forecast period. Photopheresis process is expected to have a higher growth rate in the forecast period is primarily due to an increasing rate of efficiency in the case of treating CTCL. Further, advancement in the technologies used for photopheresis process and increasing rate of cancer and skin disorders also drive the market.

Scope Of The Global Apheresis Equipment Market: Inquire before buying

Global Apheresis Equipment Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.62 Bn.
Forecast Period 2023 to 2029 CAGR: 10.9% Market Size in 2029: US $ 7.48 Bn.
Segments Covered: by Process o Plateletpheresis o Leukapheresis o Plasmapheresis o Erythrocytapheresis o Others
by Products o Disposables o Devices
by Application o Blood Collection o Treatment • Neurology • Haematology • Renal diseases •  Others
by Technology oCentrifugation o Membrane Filtration

Apheresis Equipment Market, by Region

North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

Apheresis Equipment Market Key Players are:

o Cerus Corporation o Fresenius Medical Care o Asahi Kasei Medical o Fenwal o Kawasumi Laboratories o Haemonetics Corporation o Terumo Bct o Kaneka Corporation o Hemacare Corporation o Therakos Frequently Asked questions 1. Which region has the largest share in Global Apheresis Equipment Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Apheresis Equipment Market? Ans: The Global Apheresis Equipment Market is growing at a CAGR of 10.9% during forecasting period 2023-2029. 3. What is scope of the Global Apheresis Equipment Market report? Ans: Global Apheresis Equipment Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Apheresis Equipment Market? Ans: The important key players in the Global Apheresis Equipment Market are – Cerus Corporation, Fresenius Medical Care, Asahi Kasei Medical, Fenwal, Kawasumi Laboratories, Haemonetics Corporation, Terumo Bct, Kaneka Corporation, Hemacare Corporation, Therakos. 5. What is the study period of this Market? Ans: The Global Apheresis Equipment Market is studied from 2022 to 2029.

Global Apheresis Equipment Market

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Apheresis Equipment Market overview 2.1.1. By Process 2.1.2. By Products 2.1.3. By Application 2.1.4. By Technology Chapter 3 Global Apheresis Equipment Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. High incidence rates of hospital acquired infections 3.2.2. Market Restrains 3.2.2.1. High-cost products 3.3. Market share analysis 3.3.1. By Process 3.3.2. By Products 3.3.3. By Application 3.3.4. By Technology 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Apheresis Equipment Market, By Process 4.1. Key segment trends 4.2. Plateletpheresis 4.2.1. Market size, by region, 2022 – 2029 4.3. Leukapheresis 4.3.1. Market size, by region, 2022 – 2029 4.4. Plasmapheresis 4.4.1. Market size, by region, 2022 – 2029 4.5. Erythrocytapheresis 4.5.1. Market size, by region, 2022 – 2029 4.6. Others 4.6.1. Market size, by region, 2022 – 2029 Chapter 5 Apheresis Equipment Market, By Products 5.1. Key segment trends 5.2. Disposables 5.2.1. Market size, by region, 2022 – 2029 5.3. Devices 5.3.1. Market size, by region, 2022 – 2029 Chapter 6 Apheresis Equipment Market, By Applications 6.1. Key segment trends 6.2. Blood Collection 6.2.1. Market size, by region, 2022 – 2029 6.3. Treatment 6.3.1. Market size, by region, 2022 – 2029 6.4. Neurology 6.4.1. Market size, by region, 2022 – 2029 6.5. Haematology 6.5.1. Market size, by region, 2022 – 2029 6.6. Renal diseases 6.6.1. Market size, by region, 2022 – 2029 6.7. Others 6.7.1. Market size, by region, 2022 – 2029 Chapter 7 Apheresis Equipment Market, By Technology 7.1. Key segment trends 7.2. Centrifugation 7.2.1. Market size, by region, 2022 – 2029 7.3. Membrane Filtration 7.3.1. Market size, by region, 2022 – 2029 Chapter 8 Apheresis Equipment Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2022 – 2029 8.2.2. Market size, by process, 2022 – 2029 8.2.3. Market size, by products, 2022 – 2029 8.2.4. Market size, by applications, 2022 – 2029 8.2.5. Market size, by technology, 2022 – 2029 8.3. U.S. 8.3.1. Market size, by process, 2022 – 2029 8.3.2. Market size, by products, 2022 – 2029 8.3.3. Market size, by applications, 2022 – 2029 8.3.4. Market size, by technology, 2022 – 2029 8.4. Canada 8.4.1. Market size, by process, 2022 – 2029 8.4.2. Market size, by products, 2022 – 2029 8.4.3. Market size, by applications, 2022 – 2029 8.4.4. Market size, by technology, 2022 – 2029 8.5. Europe 8.5.1. Market size, by country, 2022 – 2029 8.5.2. Market size, by process, 2022 – 2029 8.5.3. Market size, by products, 2022 – 2029 8.5.4. Market size, by applications, 2022 – 2029 8.5.5. Market size, by technology, 2022 – 2029 8.6. Germany 8.6.1. Market size, by process, 2022 – 2029 8.6.2. Market size, by products, 2022 – 2029 8.6.3. Market size, by applications, 2022 – 2029 8.6.4. Market size, by technology, 2022 – 2029 8.7. UK 8.7.1. Market size, by process, 2022 – 2029 8.7.2. Market size, by products, 2022 – 2029 8.7.3. Market size, by applications, 2022 – 2029 8.7.4. Market size, by technology, 2022 – 2029 8. France 8.8.1. Market size, by process, 2022 – 2029 8.8.2. Market size, by products, 2022 – 2029 8.8.3. Market size, by applications, 2022 – 2029 8.8.4. Market size, by technology, 2022 – 2029 8.9. Spain 8.9.1. Market size, by process, 2022 – 2029 8.9.2. Market size, by products, 2022 – 2029 8.9.3. Market size, by applications, 2022 – 2029 8.9.4. Market size, by technology, 2022 – 2029 8.10. Italy 8.10.1. Market size, by process, 2022 – 2029 8.10.2. Market size, by products, 2022 – 2029 8.10.3. Market size, by applications, 2022 – 2029 8.10.4. Market size, by technology, 2022 – 2029 8.11. Asia Pacific 8.11.1. Market size, by country, 2022 – 2029 8.11.2. Market size, by process, 2022 – 2029 8.11.3. Market size, by products, 2022 – 2029 8.11.4. Market size, by applications, 2022 – 2029 8.11.5. Market size, by technology, 2022 – 2029 8.12. India 8.12.1. Market size, by process, 2022 – 2029 8.12.2. Market size, by products, 2022 – 2029 8.12.3. Market size, by applications, 2022 – 2029 8.12.4. Market size, by technology, 2022 – 2029 8.13. China 8.13.1. Market size, by process, 2022 – 2029 8.13.2. Market size, by products, 2022 – 2029 8.13.3. Market size, by applications, 2022 – 2029 8.13.4. Market size, by technology, 2022 – 2029 8.14. Japan 8.14.1. Market size, by process, 2022 – 2029 8.14.2. Market size, by products, 2022 – 2029 8.14.3. Market size, by applications, 2022 – 2029 8.14.4. Market size, by technology, 2022 – 2029 8.15. Australia 8.15.1. Market size, by process, 2022 – 2029 8.15.2. Market size, by products, 2022 – 2029 8.15.3. Market size, by applications, 2022 – 2029 8.15.4. Market size, by technology, 2022 – 2029 8.16. Latin America 8.16.1. Market size, by country, 2022 – 2029 8.16.2. Market size, by process, 2022 – 2029 8.16.3. Market size, by products, 2022 – 2029 8.16.4. Market size, by applications, 2022 – 2029 8.16.5. Market size, by technology, 2022 – 2029 8.17. Argentina 8.17.1. Market size, by process, 2022 – 2029 8.17.2. Market size, by products, 2022 – 2029 8.17.3. Market size, by applications, 2022 – 2029 8.17.4. Market size, by technology, 2022 – 2029 8.18. Brazil 8.18.1. Market size, by process, 2022 – 2029 8.18.2. Market size, by products, 2022 – 2029 8.18.3. Market size, by applications, 2022 – 2029 8.18.4. Market size, by technology, 2022 – 2029 8.19. Mexico 8.19.1. Market size, by process, 2022 – 2029 8.19.2. Market size, by products, 2022 – 2029 8.19.3. Market size, by applications, 2022 – 2029 8.19.4. Market size, by technology, 2022 – 2029 8.20. Middle East and Africa 8.20.1. Market size, by country, 2022 – 2029 8.20.2. Market size, by process, 2022 – 2029 8.20.3. Market size, by products, 2022 – 2029 8.20.4. Market size, by applications, 2022 – 2029 8.20.5. Market size, by technology, 2022 – 2029 8.21. South Africa 8.21.1. Market size, by process, 2022 – 2029 8.21.2. Market size, by products, 2022 – 2029 8.21.3. Market size, by applications, 2022 – 2029 8.21.4. Market size, by technology, 2022 – 2029 8.22. Saudi Arabia 8.22.1. Market size, by process, 2022 – 2029 8.22.2. Market size, by products, 2022 – 2029 8.22.3. Market size, by applications, 2022 – 2029 8.22.4. Market size, by technology, 2022 – 2029 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis 9.4. Key players 9.4.1. Asahi Kasei Medical Co., Ltd 9.4.1.1. Company overview 9.4.1.2. Key financials 9.4.1.3. Product landscape 9.4.1.4. Strategic initiatives 9.4.1.5. SWOT analysis 9.4.2. B Braun Melsungen AG 9.4.2.1. Company overview 9.4.2.2. Key financials 9.4.2.3. Product landscape 9.4.2.4. Strategic initiatives 9.4.2.5. SWOT analysis 9.4.3. Cerus Corporation 9.4.3.1. Company overview 9.4.3.2. Key financials 9.4.3.3. Product landscape 9.4.3.4. Strategic initiatives 9.4.3.5. SWOT analysis 9.4.4. Fresenius Kabi 9.4.4.1. Company overview 9.4.4.2. Key financials 9.4.4.3. Product landscape 9.4.4.4. Strategic initiatives 9.4.4.5. SWOT analysis 9.4.5. Haemonetics Corporation 9.4.5.1. Company overview 9.4.5.2. Key financials 9.4.5.3. Product landscape 9.4.5.4. Strategic initiatives 9.4.5.5. SWOT analysis 9.4.6. Kaneka Corporation 9.4.6.1. Company overview 9.4.6.2. Key financials 9.4.6.3. Product landscape 9.4.6.4. Strategic initiatives 9.4.6.5. SWOT analysis 9.4.7. Kawasumi Laboratories, Inc. 9.4.7.1. Company overview 9.4.7.2. Key financials 9.4.7.3. Product landscape 9.4.7.4. Strategic initiatives 9.4.7.5. SWOT analysis 9.5. Mallinckrodt Pharmaceuticals 9.5.1.1. Company overview 9.5.1.2. Key financials 9.5.1.3. Product landscape 9.5.1.4. Strategic initiatives 9.5.1.5. SWOT analysis 9.6. Medica SpA 9.6.1.1. Company overview 9.6.1.2. Key financials 9.6.1.3. Product landscape 9.6.1.4. Strategic initiatives 9.6.1.5. SWOT analysis 9.7. NIKKISO Europe GmbH 9.7.1.1. Company overview 9.7.1.2. Key financials 9.9.7.1.3. Product landscape 9.7.1.4. Strategic initiatives 9.7.1.5. SWOT analysis 9.8. Terumo BCT, Inc. 9.8.1.1. Company overview 9.8.1.2. Key financials 9.8.1.3. Product landscape 9.8.1.4. Strategic initiatives 9.8.1.5. SWOT analysis 9.9. Kawasumi Laboratories Inc. 9.9.1.1. Company overview 9.9.1.2. Key financials 9.9.1.3. Product landscape 9.9.1.4. Strategic initiatives 9.9.1.5. SWOT analysis 9.10. Therakos, Inc. 9.10.1.1. Company overview 9.10.1.2. Key financials 9.10.1.3. Product landscape 9.10.1.4. Strategic initiatives 9.10.1.5. SWOT analysis 9.11. Fenwal, Inc. 9.11.1.1. Company overview 9.11.1.2. Key financials 9.11.1.3. Product landscape 9.11.1.4. Strategic initiatives 9.11.1.5. SWOT analysis 9.12. Delcon 9.12.1.1. Company overview 9.12.1.2. Key financials 9.12.1.3. Product landscape 9.12.1.4. Strategic initiatives 9.12.1.5. SWOT analysis 9.13. Ekso Bionics 9.13.1.1. Company overview 9.13.1.2. Key financials 9.13.1.3. Product landscape 9.13.1.4. Strategic initiatives 9.13.1.5. SWOT analysis 9.14. Hocoma 9.14.1.1. Company overview 9.14.1.2. Key financials 9.14.1.3. Product landscape 9.14.1.4. Strategic initiatives 9.14.1.5. SWOT analysis 9.15. GaitTronics 9.15.1.1. Company overview 9.15.1.2. Key financials 9.15.1.3. Product landscape 9.15.1.4. Strategic initiatives 9.15.1.5. SWOT analysis 9.16. Bionik 9.16.1.1. Company overview 9.16.1.2. Key financials 9.16.1.3. Product landscape 9.16.1.4. Strategic initiatives 9.16.1.5. SWOT analysis 9.17. Barrett Technology 9.17.1.1. Company overview 9.17.1.2. Key financials 9.17.1.3. Product landscape 9.17.1.4. Strategic initiatives 9.17.1.5. SWOT analysis 9.18. Interactive Motion Technologies, Inc. 9.18.1.1. Company overview 9.18.1.2. Key financials 9.18.1.3. Product landscape 9.18.1.4. Strategic initiatives 9.18.1.5. SWOT analysis 9.19. Accuray Incorporated 9.19.1.1. Company overview 9.19.1.2. Key financials 9.19.1.3. Product landscape 9.19.1.4. Strategic initiatives 9.19.1.5. SWOT analysis 9.20. Omnicell, Inc. 9.20.1.1. Company overview 9.20.1.2. Key financials 9.20.1.3. Product landscape 9.20.1.4. Strategic initiatives 9.20.1.5. SWOT analysis
  • INQUIRE BEFORE BUYING